Publication Date
In 2025 | 0 |
Since 2024 | 0 |
Since 2021 (last 5 years) | 1 |
Since 2016 (last 10 years) | 1 |
Since 2006 (last 20 years) | 8 |
Descriptor
Drug Addiction | 14 |
Drug Therapy | 14 |
Patients | 14 |
Drug Abuse | 5 |
Intervention | 4 |
Narcotics | 4 |
Pharmacology | 4 |
Physicians | 4 |
Substance Abuse | 4 |
Cocaine | 3 |
Drug Rehabilitation | 3 |
More ▼ |
Source
Author
Becker, William C. | 1 |
Bigelow, George | 1 |
Bond, Kathleen | 1 |
Boone, Margaret | 1 |
Brooks, Margaret | 1 |
Brown, Nancy J. | 1 |
Budney, Alan | 1 |
Chiauzzi, Emil | 1 |
Copenhaver, Michael | 1 |
Earnshaw, Valerie | 1 |
Elkashef, Ahmed | 1 |
More ▼ |
Publication Type
Journal Articles | 11 |
Reports - Descriptive | 5 |
Reports - Research | 4 |
Information Analyses | 3 |
Reports - Evaluative | 3 |
Guides - Non-Classroom | 2 |
Education Level
Higher Education | 1 |
Audience
Location
United States | 3 |
Laws, Policies, & Programs
Americans with Disabilities… | 1 |
Assessments and Surveys
What Works Clearinghouse Rating
Graham, S. Scott – Written Communication, 2021
This article offers a longitudinal computational-rhetorical analysis of biomedical writing on opioids. Using a corpus of 1,467 articles and essays published in the "New England Journal of Medicine" and the "Journal of the American Medical Association" between 1959 and May 2019, this study evaluates diachronic shifts in (a) the…
Descriptors: Narcotics, Drug Abuse, Epidemiology, Medical Research
Earnshaw, Valerie; Smith, Laramie; Copenhaver, Michael – International Journal of Mental Health and Addiction, 2013
Experiences of stigma from others among people with a history of drug addiction are understudied in comparison to the strength of stigma associated with drug addiction. Work that has studied these experiences has primarily focused on stigma experienced from healthcare workers specifically even though stigma is often experienced from other sources…
Descriptors: Drug Addiction, Drug Therapy, Patients, Experience
Chiauzzi, Emil; Trudeau, Kimberlee J.; Zacharoff, Kevin; Bond, Kathleen – Journal of Continuing Education in the Health Professions, 2011
Introduction: Primary care physicians (PCPs) treat a high proportion of chronic pain patients but often lack training about how to assess and address issues associated with prescribing opioids when they are an appropriate component of therapy. The result may be that they may avoid treating these patients, which can lead to an undertreatment of…
Descriptors: Expertise, Concept Mapping, Pain, Physicians
Substance Abuse, 2012
This article presents abstracts from the 2011 AMERSA National Meeting. It includes 2011 best abstracts on research, programmatic, and curricular presentations.
Descriptors: Conferences (Gatherings), Conference Papers, Drug Abuse, Alcohol Abuse
Hettema, Jennifer E.; Sorensen, James L. – International Journal of Mental Health and Addiction, 2009
This policy commentary addresses a significant access to care issue that faces methadone maintenance patients seeking residential treatment in the United States. Methadone maintenance therapy (MMT) has demonstrated strong efficacy in the outpatient treatment of opiate dependence. However, many opiate dependent patients are also in need of more…
Descriptors: Residential Care, Maintenance, Residential Programs, Patients
Roy, Alec – Suicide and Life-Threatening Behavior, 2010
In order to examine risk factors for attempting suicide in heroin dependent patients, a group of 527 abstinent opiate dependent patients had a psychiatric interview and completed the Childhood Trauma Questionnaire. Patients who had or had never attempted suicide were compared on putative suicide risk factors. It was found that 207 of the 527…
Descriptors: Cocaine, Suicide, At Risk Persons, Questionnaires
Elkashef, Ahmed; Vocci, Frank; Huestis, Marilyn; Haney, Margaret; Budney, Alan; Gruber, Amanda; el-Guebaly, Nady – Substance Abuse, 2008
Marijuana is the number one illicit drug of abuse worldwide and a major public health problem, especially in the younger population. The objective of this article is to update and review the state of the science and treatments available for marijuana dependence based on a pre-meeting workshop that was presented at ISAM 2006. At the workshop,…
Descriptors: Marijuana, Public Health, Pharmacology, Patients
Preston, Kenzie L.; Ghitza, Udi E.; Schmittner, John P.; Schroeder, Jennifer R.; Epstein, David H. – Journal of Applied Behavior Analysis, 2008
We compared two strategies of prize-based contingency management (CM) in methadone-maintained outpatients. Urine was tested thrice weekly for 5 weeks pre-CM, 12 weeks CM, and 8 weeks post-CM. Participants were randomly assigned to a cocaine contingency (four prize draws for each cocaine-negative urine, N = 29) or an opiate-cocaine contingency (one…
Descriptors: Cocaine, Contingency Management, Reinforcement, Drug Use

Sideroff, Stephen I. – Journal of Drug Education, 1979
Presents a Gestalt therapeutic approach that has shown promise within a drug treatment program. The major issues discussed include the acquisition of self-support, taking responsibility, dealing with anxiety, contact, and the expression of pent-up feelings. (Author)
Descriptors: Drug Addiction, Drug Education, Drug Therapy, Helping Relationship

Murphy, John W. – Journal of Drug Education, 1979
Outlines a method of outcome evaluation which allows for a client to be tracked throughout a treatment episode, so that a client's behavioral status can be assessed while remaining in treatment. (Author)
Descriptors: Behavior Change, Drug Addiction, Drug Therapy, Measurement Techniques
Bigelow, George; And Others – 1976
The Treatment Evaluation Project was established to evaluate the feasibility of using behavioral treatment in conjunction with methadone maintenance to improve the effectiveness of methadone treatment. Over 100 outpatients were accepted into treatment and randomly assigned to one of four behavioral treatment modalities in addition to the usual…
Descriptors: Behavior Change, Clinics, Contingency Management, Desensitization
Wong, Jeffrey G.; Holmboe, Eric S.; Becker, William C.; Fiellin, David A.; Jara, Gail B.; Martin, Judith – Substance Abuse, 2005
The Drug Addiction Treatment Act of 2000 (DATA-2000) allows qualified physicians to treat opioid-dependent patients with schedule III-V medications, such as buprenorphine, in practices separate from licensed, accredited opioid treatment programs. Physicians may attain this qualification by completing 8-hours of training in treating opioid…
Descriptors: Physicians, Drug Addiction, Training, Patients
Tinkler, Emily; Vallejos Bartlett, Catalina; Brooks, Margaret; Gilbert, Johnatnan Max; Henderson, Randi; Shuman, Deborah, J. – Substance Abuse and Mental Health Services Administration, 2005
TIP 43 provides best-practice guidelines for medication-assisted treatment of opioid addiction in opioid treatment programs (OTPs). The primary intended audience for this volume is substance abuse treatment providers and administrators who work in OTPs. Recommendations in the TIP are based on both an analysis of current research and determinations…
Descriptors: Program Effectiveness, Patients, Substance Abuse, Ethics
Boone, Margaret; Brown, Nancy J.; Moon, Mary A.; Schuman, Deborah J.; Thomas, Josephine; Wright, Denise L. – Substance Abuse and Mental Health Services Administration, 2004
This Treatment Improvement Protocol (TIP) addresses the clinical use of buprenorphine in the treatment of opioid addiction. TIPs are best-practice guidelines for the treatment of substance use disorders that make the latest research in substance abuse treatment available to counselors and educators. The content was generated by a panel of experts…
Descriptors: Pharmacology, Physicians, Guidelines, Physiology